Europe Flu Vaccine Market Size study by Product and Application Analysis with Forecast to 2022


Posted February 6, 2020 by prachitisharma98

The EMEA Flu Vaccine market was valued at 808.63 Million USD in 2017 and will reach 1185.08 Million USD by the end of 2022, growing at a CAGR of 7.94% during 2017-2022
 
Bharat Book Bureau Provides the Trending Market Research Report on “Europe Flu Vaccine Market Report 2019 ”under Life Sciences Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.

In this report, EMEA Flu Vaccine Market will reach 1185.08 Million USD by the end of 2022 with a CAGR of 7.94%

The EMEA Flu Vaccine market was valued at 808.63 Million USD in 2017 and will reach 1185.08 Million USD by the end of 2022, growing at a CAGR of 7.94% during 2017-2022.

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Flu Vaccine can be divided into four categories: Whole Virus Vaccines type, Split Virus Vaccines type, Subunit Vaccines type and Live Attenuated Virus Vaccines type. Whole Virus Vaccines type accounted for the highest proportion in sales market, with a figure of 43.15% in 2017, followed by Subunit Vaccines, account for 19.57% and Split Virus Vaccines type accounted for 18.93%.

Request a free sample copy Flu Vaccine Market Report @
https://www.bharatbook.com/marketreports/sample/reports/1943551

The sales market share of EMEA Flu Vaccine in For Children (6 months to 3 years) use and For Adults and Children over 3 years use has been stable year by year, at 23.21% and 76.79% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Flu Vaccine in the EMEA market tends to be fixed without great changes. Among them, the Flu Vaccine market has the most promising sales prospects in For Adults and Children over 3years use.

This research center data shows that Europe is the biggest contributor to the Flu Vaccine revenue market, accounted for 81.08% of the total EMEA market with a revenue of 655.61 million USD in 2017, followed by Middle East, 11.75% with a revenue of 94.99 million USD.

Market competition is not intense. CSL, GSK, Sanofi Pasteur, Mylan, AstraZeneca, Pfizer and Johnson & Johnson, etc. are the leaders of the industry in the EMEA, with high-end customers in the Flu Vaccine market.

Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Flu Vaccine for these regions, from 2014 to 2022 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain

Europe Flu Vaccine market competition by top manufacturers/players, with Flu Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Flu Vaccine for each application, including
For Children (6 months to 3 years)
For Adults and Children over 3 years

If you have any special requirements, please let us know and we will offer you the report as you want.

Browse our full report with Table of Content :
https://www.bharatbook.com/marketreports/europe-flu-vaccine-market-report-2019/1943551

About - Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Prachiti Sharma
Phone 27810773
Business Address 808, Real Tech Park, 8th Floor, Sector -
30A, Vashi, Navi Mumbai - 400703, India.
Country India
Categories Business , Health
Tags europe flu vaccine market , europe flu vaccine market demand , europe flu vaccine market forecast , europe flu vaccine market growth , europe flu vaccine market outlook , europe flu vaccine market report , europe flu vaccine market research report , europe flu vaccine market trends
Last Updated February 6, 2020